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Abstract 
Background: Lymphedema is a common complication of breast cancer treatment. And while breast 
cancer survivors are at an increased risk of developing lymphedema, there are various risk factors that, if 
avoided, might limit the incidence of arm swelling. A few national organizations have recommended that 
patients avoid blood pressure measurements on the affected arm. The purpose of this systematic review 
is to determine whether this burden is evidence-based or if it is causing unnecessary health anxiety. 
Methods: An exhaustive search of available medical literature was performed using MEDLINE-PubMed, 
Web of Science, and CINAHL. Key words included “blood pressure” and “lymphedema” and (“breast 
cancer” or “breast neoplasm”). The quality of evidence was assessed using the GRADE Working Group 
guidelines. 
Results: A total of 4 articles were included in this systematic review, all of which were prospective cohort 
studies. Three studies found no significantly increased risk of lymphedema with blood pressure 
measurements. One study measured lymphedema using 3 different techniques and found a significantly 
increased risk with one of the techniques but not the others. 
Conclusion: This systematic review refutes the current guidelines that patients should avoid blood 
pressure monitoring in the affected arm. Further research that looks at how to define lymphedema and 
how to best diagnose it in the clinic will help with implementing earlier treatment. 
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Abstract 
Background: Lymphedema is a common complication of breast 
cancer treatment. And while breast cancer survivors are at an 
increased risk of developing lymphedema, there are various risk 
factors that, if avoided, might limit the incidence of arm swelling. A 
few national organizations have recommended that patients avoid 
blood pressure measurements on the affected arm. The purpose of this 
systematic review is to determine whether this burden is evidence-
based or if it is causing unnecessary health anxiety.  
Methods:  An exhaustive search of available medical literature was 
performed using MEDLINE-PubMed, Web of Science, and CINAHL. Key 
words included “blood pressure” and “lymphedema” and (“breast 
cancer” or “breast neoplasm”). The quality of evidence was assessed 
using the GRADE Working Group guidelines.  
Results:  A total of 4 articles were included in this systematic review, 
all of which were prospective cohort studies. Three studies found no 
significantly increased risk of lymphedema with blood pressure 
measurements. One study measured lymphedema using 3 different 
techniques and found a significantly increased risk with one of the 
techniques but not the others.   
Conclusion:  This systematic review refutes the current guidelines 
that patients should avoid blood pressure monitoring in the affected 
arm. Further research that looks at how to define lymphedema and 
how to best diagnose it in the clinic will help with implementing earlier 
treatment.  
Keywords: Blood pressure, lymphedema, breast cancer, and breast 
neoplasm 
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Blood Pressure Measurement as a Risk Factor 




Lymphedema is abnormal swelling, generally in an arm or leg, 
which is caused by a blockage in the lymphatic system. This blockage 
can be caused by the removal of lymph nodes or damage to the 
lymphatic vessels. One of the most common risk factors for developing 
lymphedema is prior lymphadenectomy, a procedure often performed 
in conjunction with breast cancer surgery.1 Although removal of lymph 
nodes is vital to the initial assessment of early breast cancer, patients 
can try to prevent further damage to the lymphatic vessels by limiting 
their exposure to potentially harmful events.  
 However, many of the lifestyle changes that providers 
recommend to patients are anecdotal or based on a textbook 
understanding of how the body functions. Providers are operating on a 
“can’t hurt so why not” basis. Recommendations that are not 
evidence-based are causing unnecessary anxiety and fear in breast 
cancer survivors.2  
 The theory behind the increased risk with blood pressure 
measurement stems from the idea that a cuff increases pressure in the 
arm in a focused area. This focused compression might cause further 
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damage to the lymphatic vessels and lead to an increase in lymph 
production.3 However, some research suggests that increased pressure 
in the affected arm should not be contraindicated because the 
treatment of lymphedema is in fact compression.4 
There have been many recent studies that highlight the various 
risk factors for developing breast cancer related lymphedema (BCRL). 
Despite these findings, current guidelines from the National 
Lymphedema Network (NLN)5 and the National Cancer Institute (NCI)6 
continue to advise against blood pressure monitoring in the affected 
arm. The purpose of this systematic review is to resolve the question: 
Can measuring blood pressure post breast cancer treatment increase 
the incidence of lymphedema? 
METHODS 
An exhaustive literature search was conducted in June 2017 
using MEDLINE-PubMed, Web of Science, and CINAHL. Keywords 
searched included “blood pressure” and “lymphedema” and (“breast 
cancer” or “breast neoplasm”). Articles that summarized relevant 
evidence were searched for further sources. Studies were excluded if 
they did not analyze BP measurement as a separate variable. The 
articles were assessed for quality using the Grading of 
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Recommendations Assessment, Development and Evaluation (GRADE) 
Working Group guidelines.7    
RESULTS 
From the initial literature search, 40 articles were reviewed for 
relevance. One article was excluded because it did not analyze blood 
pressure measurement as a separate variable but rather as part of a 
group of medical procedures, which included blood draws. Two articles 
were selected directly from the database search and 2 articles were 
selected after reviewing articles that summarized relevant research. All 
4 studies8-11 were prospective cohort studies published between 2005 
and 2016. See Tables I-III. 
Kilbreath et al  
 This multicenter, prospective cohort study8 looked at 450 women 
who were diagnosed with breast cancer and scheduled for axillary 
surgery between 2009 and 2013. The study excluded women who had 
a pacemaker or who were diagnosed with stage IV cancer. The women 
were assessed prior to surgery, within 4 weeks postoperatively, and at 
6, 12, and 18 months postoperatively. Participants recorded post-
surgical events that might increase the risk of lymphedema in weekly 
diaries. The entries were completed either online, over the phone, or 
using a paper diary. Lymphedema was diagnosed using bioimpedance 
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spectroscopy (BIS). An impedance ratio greater than the normal 
threshold or increased by at least 0.1 from baseline was considered 
significant swelling.8 
 Of the 450 women, 241 (54%) had <5 nodes removed and 209 
(46%) had ≥5 nodes removed. Only 8 (3.3%) participants with <5 
nodes removed were diagnosed with lymphedema. The researchers 
concluded that there were insufficient events to identify risk factors for 
this group. The rest of the findings pertain only to the group with ≥5 
nodes removed.8  
 Diaries were available for 112 participants, of which 21 were 
diagnosed with lymphedema at the 18-month assessment. Results 
showed 20.3% of women who recorded having at least 1 blood 
pressure measured (N=55) presented with lymphedema as compared 
to 16.3% of women who recorded never having blood pressure 
measured (N=36). The OR for blood pressure measured was 1.3 (95% 
CI 0.5, 3.6) with a p-value of 0.6. These results demonstrate no 
significant risk of lymphedema with blood pressure measurement in 
women with ≥5 nodes removed.8 
Ferguson et al  
 This prospective cohort study9 was conducted on 632 patients 
who were diagnosed with breast cancer and underwent treatment at 
Massachusetts General Hospital between 2005 and 2014. Patients who 
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underwent sentinel lymph node biopsy or axillary lymph node 
dissection and who were prospectively screened for lymphedema 
preoperatively were included in the study. Patients who were 
diagnosed with distant metastasis or wore a compression sleeve while 
flying were excluded.9  
 All patients were assessed preoperatively, postoperatively, and 
at regular follow-up intervals that ranged between 3 and 7 months. On 
average, patients had 4 follow-up visits over a span of 24 months. 
Lymphedema was diagnosed using an optoelectric Perometer, which 
measures arm volume changes. A relative volume change or weight-
adjusted volume change ≥10% was determined to be significant. At 
each visit, a Perometer measurement was taken and patients 
completed a survey in which they were asked to recall how many 
blood pressure readings they had had since the previous visit.9  
 Throughout the surveys, a total of 482 responses reported 
having at least 1 blood pressure measured and 2,479 reported never 
having blood pressure measured. The results showed that only 2.5% 
of responses with at least 1 blood pressure measured presented with 
lymphedema, as compared to 7.0% of responses that never had blood 
pressure measured. The OR for blood pressure measured was 0.34 
with a p-value of 0.0338 (95% CI -0.72, 0.25).   
Showalter et al  
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 This prospective sub-analysis of a randomized controlled study10 
looked at 295 breast cancer survivors recruited between October 2005 
and February 2007. The participants were either at risk for developing 
lymphedema (1-5 years post breast cancer diagnosis) or had stable 
lymphedema (1-15 years post breast cancer diagnosis). Participants 
who had undergone intensive breast cancer related lymphedema 
(BCRL) therapy, recorded a 10% change in volume or circumference of 
the arm lasting for ≥7 days, at least 2 BCRL-related infections, or a 
BCRL exacerbation that lead to a change in daily activities, within the 
past 3 months were excluded from the study.10  
 The original RCT aimed to assess the effects of weight lifting on 
BCRL. All participants were instructed to wear a compression sleeve 
and attend a 1-hour lecture on lymphedema education. The presence 
of lymphedema was measured using water volume displacement. 
Significant lymphedema was defined as an inter-limb volume of 
difference ≥5% with a ≥5% increase since the last measurement. Arm 
volume was measured at baseline (time of entry into the study) and 3, 
6, and 12 months. At each visit, participants were asked to complete a 
questionnaire and recall if they were exposed to a blood pressure cuff 
within the past 3 months.10 
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The study found blood pressure reading was not a significant risk 
factor for lymphedema. The OR was 1.47 (95% CI 0.18, 11.77) with a 
p-value of 0.72.10   
Hayes et al  
 This prospective cohort study11 analyzed 176 women 6 months 
post-breast cancer surgery. Participants residing within a 100km 
radius of Brisbane were randomly selected from the Queensland 
Cancer Registry in 2005. Women ≤75 years old diagnosed with 
unilateral breast cancer within the previous 6 months were included in 
the study.11  
 One of the primary focuses of the study was to analyze the 
difference in lymphedema measurement techniques. The study looked 
at 2 objective measures, multifrequency bioelectrical impedance 
(MFBIA) and difference between sum of arm circumferences (SOAC), 
and one subjective measure, self-report. Lymphedema was defined as 
an impedance ratio greater than 3 standard deviations above normal, 
or a difference between SOAC greater than 5cm or 10%, or a “yes” 
response on the self-report. Due to its accurate and reliable 
measurements, the MFBIA technique was considered the reference 
standard. The self-report assessed a period of 6 months and showed 
the highest sensitivity. While difference in SOAC is the most popular 
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technique in practice, the study found it to have the lowest sensitivity 
and poor repeatability.11  
 At the time of lymphedema measurement, participants were 
asked to recall if they had blood pressure readings from the treated 
side during the previous 6 months. The results identified blood 
pressure readings as a significant risk factor for the presence of 
lymphedema. In those who had experienced blood pressure readings, 
the OR was 3.4 (95% CI 1.0, 11.1) when assessed using difference in 
SOAC >5cm. However, significance was not found with MFBIA OR 1.1 
(0.2, 5.4) or self-report OR 1.5 (0.5, 4.4).11  
DISCUSSION 
At first glance, the results of these studies are at best eye 
opening but not quite practice-changing. Three of the 4 studies8-10 
refute the current recommendations to avoid blood pressure 
measurements in the affected arm following treatment for breast 
cancer. One study11 claims to neither support nor refute the NLN and 
NCI, despite finding an increased risk of lymphedema with blood 
pressure measurement (See Table I).   
 The purpose of this systematic review is to resolve this literature 
conflict and determine if the burden placed on patients is evidence-
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based. Each of the articles was evaluated using GRADE criteria to 
assess the quality of evidence, presented in Table II.  
Upon reviewing the articles, there was inconsistency in the 
findings in regards to the outcome of lymphedema. Ferguson et al9 
found significance (p=0.034) by univariate analysis, but reported that 
the finding was no longer significant (p=0.15) when the data was 
analyzed as continuous variables or by multivariate analysis. The study 
concluded that blood pressure measurement does not increase the risk 
of lymphedema. Hayes et al11 was the one study that found blood 
pressure measurement to be a significant risk factor for developing 
lymphedema. However, the study focused on how to diagnose 
lymphedema using 3 different methods: MFBIA, difference in SOAC 
>5cm, and self-report. Significance was only found when lymphedema 
was assessed by difference in SOAC. Yet the article states that the 
MFBIA technique is the ‘reference standard’ because of its accuracy. 
Asdourian et al,12 who also reviewed similar resources, agrees that the 
inconsistency limits the influence this significant finding has on the 
current discussion. Furthermore, measurement of arm circumference 
via tape measure has some degree of subjectivity and the data 
collectors were not blinded.11 
 While the results of these studies suggest that the current 
guidelines need to be updated in regards to blood pressure 
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measurements, they also introduce new problems into the discussion 
on preventing lymphedema (see Table III). Throughout the 4 studies, 
5 different techniques were utilized to diagnose the presence of 
lymphedema: MFBIA, Perometer, water volume displacement, 
difference in SOAC, and self-report. This methodology led to 5 
different definitions of what constitutes lymphedema. The water 
volume displacement in Showalter et al10 did not account for changes 
in overall body weight nor did the difference in SOAC in Hayes et al.11 
Both Ferguson et al9 and Kilbreath et al8 utilized objective measures of 
lymphedema, Perometer and MFBIA respectively, to define 
lymphedema.  
 Other issues that impact the outcome of these studies were the 
length of follow-up and the measurement of exposure to blood 
pressure cuff readings. The average time it takes to develop 
lymphedema following breast cancer treatment is 14.4 months.9 While 
Ferguson et al9 followed patients for 24 months and Kilbreath et al8 18 
months, Showalter et al10 only followed patients for 12 months and 
Hayes et al11 for only 6 months. This suggests that the latter 2 studies 
might underestimate the presence of lymphedema due to not long 
enough follow-up. The problem with measuring exposure to blood 
pressure cuff readings is the influence of recall bias. Hayes et al11 
asked patients to recall their exposures over the past 6 months via 
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survey, Showalter et al10 over the past 3 months via questionnaire, 
and Ferguson et al9 up to 7 months via survey. Kilbreath et al8 sought 
to eliminate this confounding variable and asked patients to keep a 
diary that they filled out weekly. If at any time a diary entry was not 
submitted, a research assistant contacted the participant via phone.  
 Despite some of the differences in methodology, all of the 
studies evaluated breast cancer survivors status post breast cancer 
treatment. However, each of the studies was composed of a slightly 
different patient population. Hayes et al11 looked at participants from a 
100km radius in Brisbane, which might limit its generalizability. 
Showalter et al10 was a sub-analysis of a randomized controlled study. 
This meant that all participants were capable of weight-lifting, 
attended a 1-hour educational lecture on lymphedema, and were 
encouraged to wear a compression sleeve. Some of the participants 
were 15 years post diagnosis and the study did not take into account 
exposures prior to the start of the study. All of these variables suggest 
that the study’s population might be less susceptible to developing 
lymphedema than the general population. Kilbreath et al8 was the only 
study that limited its analysis to participants with 5 or more lymph 
nodes removed. Even though this study was evaluating a high-risk 
group, it still failed to find significance with blood pressure 
measurements.  
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 As prospective cohort studies, each of the studies started off as 
a low quality evidence meaning further research is very likely to 
change the estimate of effect. Both Hayes et al11 and Showalter et al10 
were downgraded to a very low quality of evidence. Ferguson et al9 
and Kilbreath et al8 were both published within the past 2 years and 
sought to address some of the methodological confounders that 
downgraded the other 2 studies. With ethical concerns restricting the 
possibility of a randomized controlled study, it is unlikely that any new 
research will contradict these findings. The best evidence-based 
research5,6 refutes the current recommendations to avoid blood 
pressure monitoring in the affected arm.5,6  
 As a result of these recent findings, in clinical practice, patients 
who undergo sentinel lymph node biopsy should not be given any 
recommendations in regards to blood pressure monitoring. Patients 
who undergo axillary lymph node dissection should be encouraged to 
undergo normal blood pressure monitoring, unless repeated 
measurements are required, as in the ICU or recovery room.  
CONCLUSION 
 In theory, it makes sense to avoid blood pressure measurements 
in order to prevent lymphedema; however, in practice, that does not 
seem to be the case. Even in patients with the highest risk of 
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developing lymphedema (≥5 nodes removed), there was no increased 
risk after being exposed to blood pressure readings. For patients that 
have undergone the stress of breast cancer and have plenty of worry 
and limitations, eliminating this one worry would be ethical.  
 These findings refute the current national guidelines that 
recommend patients avoid blood pressure monitoring in the effected 
arm. Although at very low risk, lymphedema can lead to pain, 
restricted function, and disfigurement and cautionary behavior should 
be followed, but blood pressure measurements do not appear to pose 
a serious risk to these patients.13,14 Clinicians can protect their patients 
from health anxiety and stress by limiting this lifestyle restriction. 
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Table I. Summary of Findings 
 Odds ratio 95% Confidence Interval 
Kilbreath et al8 1.3 (0.5, 3.6) 
Ferguson et al9 0.34  
Showalter et al10 1.47 (0.18, 11.77) 
Hayes et al11 3.4 (1.0, 11.1) 
 
 
Table II. Quality Assessment of Reviewed Studies 
Study Design Downgrade Criteria Upgrade 
Criteria 
Quality 




Cohort Not serious Not serious Not serious Not serious Unlikely None Low 
Ferguson 
et al9 
Cohort Not serious  Not serious Seriousa Not serious Unlikely  None Low 
Showalter 
et al10 




Cohort Seriousc Not serious  Seriousd Not serious  Unlikely  N/A  Very 
low  
a Significance with univariate analysis but not with multivariate analysis 
b Cohort is not generalizable (lymphedema education, compression sleeve, capable of weight lifting), does not consider 
exposures prior to the start of the study (some are 15 years post diagnosis) 
c Lack of blinding of data collectors – significant finding was based on arm measurements; and high risk of recall bias 
influencing data collection  
d Reference standard did not prove significance  
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Table III. Summary of Significant and Non-significant Risk Factors for Lymphedema 
 
 
 Kilbreath et al8 Ferguson et al9 Showalter et al10 Hayes et al11 
Significant  ≥5 nodes removed 
Radiation therapy 
Taxane-based chemo 
High body weight at dx 
Blood draws 
Arm swelling at 12mos. 
Arm swelling at 6mos. 
BMI ≥25 
Axillary LN dissection 
Cellulitis 
Radiation therapy  
 





Tx on non-dominant side 
 










Number of flights 










# of nodes removed 
Radiation therapy 
Chemotherapy 
Injections 
Flying 
Arm trauma 
 
 
 
